August 2022: New molecular test proves reliable for early detection of womb cancer

A new publication from the Professor Martin Widschwendter and the EUTOPS team in the Journal of Clinical Oncology describes a new molecular "WID™-qEC test" that detects endometrial cancer quickly and with high accuracy using a cervical smears or a vagina swab. The test offers many advantages over currently used methods of early detection, such as ultrasound. In the future, with this easy-to-perform test, many women with suspected endometrial cancer could be spared very stressful hysteroscopies and biopsies. 

EUTOPS Institute

Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.

Meet the Team

We are a dynamic and international team with wide range of expertise.